» Articles » PMID: 17479364

Medication Adherence in Heart Failure

Overview
Journal Heart Fail Rev
Date 2007 May 5
PMID 17479364
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Non-adherence with medical regimens in heart failure is a significant challenge and serves as a major reason that favorable outcomes associated with various therapies evaluated in clinical trials have not translated to the so-called real-world setting. Non-adherence has complex influences and is clearly associated with poorer outcomes. The approaches that are used or have been proposed to improve drug-taking behavior, such as in-hospital initiation of therapy, simplification of dosing regimens through adoption of combination and long-acting formulations, and improvements in provider-patient communication, are reviewed.

Citing Articles

Patient and economic benefits of psychological support for noncompliant patients.

Reed P, Osborne L, Whittall C, Emery S, Truzoli R Front Psychol. 2022; 13:829880.

PMID: 36186372 PMC: 9521354. DOI: 10.3389/fpsyg.2022.829880.


"When you're homeless, they look down on you": A qualitative, community-based study of homeless individuals with heart failure.

Pendyal A, Rosenthal M, Spatz E, Cunningham A, Bliesener D, Keene D Heart Lung. 2020; 50(1):80-85.

PMID: 32792114 PMC: 7738391. DOI: 10.1016/j.hrtlng.2020.08.001.


Practical Applications for Single Pill Combinations in the Cardiovascular Continuum.

Iellamo F, Werdan K, Narkiewicz K, Rosano G, Volterrani M Card Fail Rev. 2017; 3(1):40-45.

PMID: 28785474 PMC: 5494156. DOI: 10.15420/cfr.2017:5:1.


Medication Adherence Mediates the Relationship Between Heart Failure Symptoms and Cardiac Event-Free Survival in Patients With Heart Failure.

Wu J, Moser D J Cardiovasc Nurs. 2017; 33(1):40-46.

PMID: 28591004 PMC: 5714687. DOI: 10.1097/JCN.0000000000000427.


Gender Differences in Cognitive Test Performance in Adults With Heart Failure.

Rochette A, Spitznagel M, Sweet L, Cohen R, Josephson R, Hughes J J Cardiovasc Nurs. 2016; 32(3):212-217.

PMID: 27028589 PMC: 5042804. DOI: 10.1097/JCN.0000000000000330.


References
1.
Krumholz H, Baker D, Ashton C, Dunbar S, FRIESINGER G, Havranek E . Evaluating quality of care for patients with heart failure. Circulation. 2000; 101(12):E122-40. DOI: 10.1161/01.cir.101.12.e122. View

2.
Gattis W, OConnor C, Gallup D, Hasselblad V, Gheorghiade M . Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol. 2004; 43(9):1534-41. DOI: 10.1016/j.jacc.2003.12.040. View

3.
Amabile C, Spencer A . Keeping your patient with heart failure safe: a review of potentially dangerous medications. Arch Intern Med. 2004; 164(7):709-20. DOI: 10.1001/archinte.164.7.709. View

4.
Fonarow G, Gheorghiade M, Abraham W . Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review. Am J Cardiol. 2004; 94(9):1155-60. DOI: 10.1016/j.amjcard.2004.07.083. View

5.
Wolbrette D, Naccarelli G . Management of implantable cardioverter defibrillator patients: role of predischarge electrophysiologic testing and proper patient instruction before hospital discharge. Curr Opin Cardiol. 2000; 16(1):72-5. DOI: 10.1097/00001573-200101000-00011. View